1 Girlich D, "Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae" 50 : 477-479, 2012
2 Song W, "Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extendedspectrum beta-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis" 57 : 315-318, 2007
3 Andes D, "Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations" 11 (11): 10-17, 2005
4 Nordmann P, "The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria" 9 : 228-236, 2009
5 Paul M, "Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis" 54 : 4851-4863, 2010
6 Shin SY, "Resistance to carbapenems in sequence type 11 Klebsiella pneumoniae is related to DHA-1 and loss of OmpK35 and/or OmpK36" 61 : 239-245, 2012
7 Dortet L, "Rapid identification of carbapenemase types in Enterobacteriaceae and Pseudomonas spp. by using a biochemical test" 56 : 6437-6440, 2012
8 Nordmann P, "Rapid detection of carbapenemaseproducing Enterobacteriaceae" 18 : 1503-1507, 2012
9 Daikos GL, "Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections" 53 : 1868-1873, 2009
10 Park YJ, "Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli" 71 : 87-89, 2011
1 Girlich D, "Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae" 50 : 477-479, 2012
2 Song W, "Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extendedspectrum beta-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis" 57 : 315-318, 2007
3 Andes D, "Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations" 11 (11): 10-17, 2005
4 Nordmann P, "The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria" 9 : 228-236, 2009
5 Paul M, "Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis" 54 : 4851-4863, 2010
6 Shin SY, "Resistance to carbapenems in sequence type 11 Klebsiella pneumoniae is related to DHA-1 and loss of OmpK35 and/or OmpK36" 61 : 239-245, 2012
7 Dortet L, "Rapid identification of carbapenemase types in Enterobacteriaceae and Pseudomonas spp. by using a biochemical test" 56 : 6437-6440, 2012
8 Nordmann P, "Rapid detection of carbapenemaseproducing Enterobacteriaceae" 18 : 1503-1507, 2012
9 Daikos GL, "Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections" 53 : 1868-1873, 2009
10 Park YJ, "Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli" 71 : 87-89, 2011
11 Ito H, "Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens" 39 : 824-829, 1995
12 Clinical and Laboratory Standards Institute, "Performance Standards for Antimicrobial Susceptibility Testing: Twenty-first Informational Supplement. Document M100-S21"
13 Clinical and Laboratory Standards Institute, "Performance Standards for Antimicrobial Susceptibility Testing: Nineteenth Informational Supplement. Document M100-S19"
14 Bin C, "Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli" 56 : 351-357, 2006
15 Paterson DL, "Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory" 39 : 2206-2212, 2001
16 Poirel L, "OXA-48-like carbapenemases: the phantom menace" 67 : 1597-1606, 2012
17 Lee K, "Novel acquired metallo-beta-lactamase gene, blaSIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea" 49 : 4485-4491, 2005
18 Woodford N, "Multiresistant gramnegative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance" 35 : 736-755, 2011
19 Schwaber MJ, "Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis" 60 : 913-920, 2007
20 Kitchel B, "Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258" 53 : 3365-3370, 2009
21 Clinical and Laboratory Standards Institute, "Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard Seventh Edition. Document M7-A7"
22 Walsh TR, "Metallo-betalactamases: the quiet before the storm?" 18 : 306-325, 2005
23 Rhee JY, "KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea" 54 : 2278-2279, 2010
24 노경호, "Isolation of a Klebsiella pneumoniae Isolate of Sequence Type 258 Producing KPC-2 Carbapenemase in Korea" 대한진단검사의학회 31 (31): 298-301, 2011
25 Coudron PE, "Inhibitor-based methods for detection of plasmidmediated AmpC beta-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis" 43 : 4163-4167, 2005
26 Song W, "In vivo selection of carbapenem-resistant Klebsiella pneumoniae by OmpK36 loss during meropenem treatment" 65 : 447-449, 2009
27 이경원, "Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009" 연세대학교의과대학 52 (52): 793-802, 2011
28 Leclercq R, "EUCAST expert rules in antimicrobial susceptibility testing" 19 : 141-160, 2013
29 European Committee on Antimicrobial Susceptibility Testing, "EUCAST clinical breakpoint v 3.1"
30 Cohen Stuart J, "Dutch Working Party on the Detection of Highly Resistant Microorganisms. Guideline for phenotypic screening and confirmation of carbapenemases in Enterobacteriaceae" 36 : 205-210, 2010
31 Giakkoupi P, "Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates" 43 : 494-496, 2005
32 Maglio D, "Determination of the in vivo pharmacodynamic profile of cefepime against extended-spectrum-beta-lactamase-producing Escherichia coli at various inocula" 48 : 1941-1947, 2004
33 Thomson KS, "Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests" 36 : 1877-1882, 1992
34 Song W, "Detection of extended-spectrum beta-lactamases by using boronic acid as an AmpC beta-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli" 45 : 1180-1184, 2007
35 Katsanis GP, "Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases" 32 : 691-696, 1994
36 Lat A, "Comparison of polymyxin B, tigecycline, cefepime, and meropenem MICs for KPC-producing Klebsiella pneumoniae by broth microdilution, Vitek 2, and Etest" 49 : 1795-1798, 2011
37 송원근, "Comparison of Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing Breakpoints for β-Lactams in Enterobacteriaceae Producing Extended-Spectrumβ-Lactamases and/or Plasmid-Mediated AmpCβ-Lactamases" 대한임상미생물학회 14 (14): 24-29, 2011
38 Tsakris A, "Comparative evaluation of combined-disk tests using different boronic acid compounds for detection of klebsiella pneumoniae carbapenemase-producing enterobacteriaceae clinical isolates" 49 : 2804-2809, 2011
39 Weisenberg SA, "Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase- producing K. pneumoniae after treatment with imipenem or meropenem" 64 : 233-235, 2009
40 Queenan AM, "Carbapenemases: the versatile betalactamases" 20 : 440-458, 2007
41 Jeong SH, "Boronic acid disk tests for identification of extended-spectrum beta-lactamase production in clinical isolates of Enterobacteriaceae producing chromosomal AmpC beta-lactamases" 31 : 467-471, 2008
42 Ho PL, "Bacteremia caused by Escherichia coli producing extended-spectrum betalactamase: a case-control study of risk factors and outcomes" 34 : 567-573, 2002
43 Livermore DM, "Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?" 67 : 1569-1577, 2012
44 Giske CG, "A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin" 17 : 552-556, 2011